HB10923: Public Health and Research Reforms in Controlled Substances Act of 2026

What the bill says

To amend the Controlled Substances Act to better align such Act with modern medical knowledge, establish a new system for the scheduling of controlled substances, redelegate certain authorities, promote scientific research, and for other purposes.

From the introduced text, October 29, 2026:

A BILL To amend the Controlled Substances Act to better align such Act with modern medical knowledge, establish a new system for the scheduling of controlled substances, redelegate certain authorities, promote scientific research, and for other purposes. SECTION 1. Short title This Act may be cited as the Public Health and Research Reforms in Controlled Substances Act of 2026 . SECTION 2. Table of contents The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. Title I--Amendments to Controlled Substances Act Sec. 101. Findings and declarations. Sec. 102. Definitions. Sec. 103. Authority and criteria for classification of substances. Sec. 104. Schedules of controlled substances. Sec. 105. Treatment of controlled substance analogues. Sec. 106. Rules and regulations. Sec. 107. Persons required to register. Sec. 108. Registration requirements. Sec. 109. Denial, revocation, or suspension of registration. Sec. 110. Quotas applicable to certain substances. Sec. 111. Records and reports of registrants. Sec. 112. Order forms. Sec. 113. Prescriptions. Sec. 114. Prohibited acts A--penalties. Sec. 115. Prohibited acts B--penalties. Sec. 116. Prohibited acts C--penalties. Sec. 117. Distribution to persons under age twenty-one. Sec. 118. Distribution in or near schools. Sec. 119. Denial of Federal benefits to drug traffickers and possessors. Sec. 120. Drug paraphernalia. Sec. 121. Administrative hearings. Sec. 122. Judicial review. Title II--Amendments to …

Read the full official text

Sponsors

• Steve Cohen (D, HD-009) · primary sponsor

Latest actions

1. October 29, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Oversight and Government Reform, Natural Resources, Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2. October 29, 2026: Introduced in House

Common questions

What is HB10923?

HB10923 is a bill in Congress (119th Congress): Public Health and Research Reforms in Controlled Substances Act of 2026.

What does HB10923 do?

In its own words: To amend the Controlled Substances Act to better align such Act with modern medical knowledge, establish a new system for the scheduling of controlled substances, redelegate certain authorities, promote scientific research, and for other purposes.

What is the status of HB10923?

In committee as of October 29, 2026. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Oversight and Government Reform, Natural Resources, Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (October 29, 2026).

Who sponsored HB10923?

Steve Cohen (D, HD-009).

Where is the official record for HB10923?

On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/10923